The postoperative analgesia afforded after colonic surgery by IV opioid, clonidine 
Improved understanding of the mechanisms governing acute pain perception has resulted in the introduction of new drugs for the management of postoperative pain. I Epidural and intravenous clonidine improve opioid postoperative analgesia. 2 ,. In a previous study, we demonstrated that the intraoperative use of IV clonidine enhances morphine patient-controlled analgesia after abdominal surgery. This beneficial effect was, however, more important for males under 65 years of age.· In the present study, the benefits of intra-and postoperative administration of clonidine are examined.
Postoperative pain prevention and postoperative pain management with drugs acting on different painmodulating systems have been illustrated by several clinical studies. shows synergistic analgesic effects with local anaesthetics. 8 ,9 In the present study, the impact on postoperative analgesia after colonic surgery of intravenous clonidine or lignocaine given intra-and postoperatively in association with opioids is evaluated.
MATERIALS AND METHODS
The study was approved by the institutional Ethics Committee. Eighty consecutive male patients, ASA physical status 1-11, aged 25 to 65, undergoing extensive left colonic resection for neoplastic disease, were enrolled. Exclusion criteria were emergency procedure, impaired renal or hepatic function, cardiac conduction disturbances, ischaemic or valvular heart disease, chronic use of clonidine, beta-blockers, tricyclic antidepressants or benzodiazepines, psychiatric illness, alcohol abuse and heavy smokers unable to stop at least one week before surgery. If any patient failed to understand the use of patient-controlled analgesia (PCA) he was excluded from the study.
All patients gave their written informed consent. The night before surgery, patients were instructed how to use the PCA device. They were asked to push the analgesic delivery button any time they experienced pain and were encouraged to push as often as required until the pain was relieved. Patients were randomly assigned to four blinded groups (Table 1) .
Pre-anaesthetic medication consisted of sublingual lorazepam 2 mg and IM atropine 0.5 mg given 45 minutes before surgery. An infusion of clonidine (4 J-tg.kg-I in 20 ml over 20 min) or saline (20 ml over 20 min) was started immediately after insertion of the venous catheter. It was followed by a continuous clonidine infusion of 2 J-tg.kg -I.h -1 or saline until closure of the peritoneum. General anaesthesia was induced with thiopentone 3-4 mg.kg-I and fentanyl 5 J-tg.kg-I . Tracheal intubation was performed after the administration of pancuronium 0.1 mg.kg-I . Normocapnia was achieved with mechanical ventilation and assessed by end-tidal C02 monitoring (Datex Capnomac®, Helsinki, Finland). Invasive arterial blood pressure monitoring was continuously recorded (Datex Cardiocap® Helsinki, Finland). Anaesthesia was maintained with 66070 nitrous oxide in oxygen and supplemented with isoflurane. Five minutes before skin incision, an additional dose of fentanyl (4 J-tg.kg-I ) and a bolus of 2 mg.kg-I in 10 mllignocaine or saline was given. Another bolus of lignocaine (2 mg.kg-I ) or saline was given before peritoneal incision and retractor placement. During the procedure, additional doses of fentanyl 2 J-tg.kg-I were given as necessary (an increase of 20070 or more of heart rate or mean arterial blood pressure recorded just before surgical incision). Pancuronium was used for maintenance of muscle relaxation.
Intraoperative analgesic drugs were titrated using the haemodynamic variations in response to the noxious stimulations of the procedure (skin incision, peritoneal incision, retractor placement). At these moments, an increase of 20070 of the basal (preincisional) mean arterial pressure and/or an increase of 20070 of the preincisional heart rate was followed by fentanyl administration.
At the end of surgery, the trachea was extubated when the patients were able to follow simple verbal commands. At this moment, patients were connected to a PCA device (Abbott Lifecare 4200) and reminded how to self-administer analgesia. The drugs delivered by request in each group are summarised in Table 1 . All the solutions were tested for possible degradation during 48 hours. The lockout interval was seven minutes and the four-hour limit was 15 ml of the analgesic solution in all the groups. No loading dose or background infusion was given.
Patients were encouraged to push the analgesic demand button any time they experienced abdominal pain and until relief was obtained. Because of the lockout interval, not every demand was satisfied. The met and unmet demands were kept in the PCA computer memory and printed at 2, 6, 12, 18, 24, 36 hours after extubation.
The quality of postoperative analgesia was inferred, for each subject, from the rate and timing of both the met and unmet PCA demands. The PCA was used as an objective way of measuring pain as initially described by Sechzer. 'o Patients were also asked to quote their analgesia at 6, 12, 18, 24, 36 postoperative hours according to a four-point analgesia scale: 0 = no pain, 1 = moderate, good control with PCA, 2 = moderate pain, poor control with PCA, 3 = unbearable pain.
The degree of sedation was determined at 6, 12, 18, 24, 36 postoperative hours according to a three-point sedation scale: 0 = alert, 1 = sleeping and arousable by verbal command, 2 = sleeping, arousable only by tactile stimulation.
Patients were also observed for bradypnoea « 8 breaths.min -I), nausea, vomiting and hallucinations. Other postoperative complications were also recorded (e.g. prolonged ileus, hypotension, bradycardia, rebound hypertension, metallic taste) during the first postoperative week. Urinary retention was not evaluated as all patients had a bladder catheter inserted for surgery. Arterial blood pressure was measured every six hours during the first postoperative week.
At the end of the observation, patients were asked to evaluate their postoperative pain relief according to a three-point satisfaction scale: 2 = excellent, 1 = good, 0 = bad. The patient's treatment group was blinded to the observer, who assessed postoperative pain relief and occurrence of side-effects. The observer was never the anaesthesiologist in charge of the patient.
The required amount of morphine during the 36-hour postoperative period has been standardised and calculated by square metre of body surface area. Statistical comparisons between means were based on ANOVA or MANOVA when appropriate, with posthoc comparison by Tukey's test. Morphine consumptions at the different postoperative six-hour epochs were analysed by ANOVA, with repeated measures. Frequencies of nausea, vomiting, sedation, analgesia and reactions to skin incision, peritoneal incision, and placement of retractors were cross-tabulated and compared with Spearman's factor. A P value of less than 0.05 was considered statistically significant.
RESULTS
No patient was excluded from the study protocol. The four groups were comparable for age, weight, height, body surface and duration of anaesthesia. There were no differences in the total dose of fentanyl. 
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Additional doses given after skin incision were, however, lower in groups B, C and D than in group A (P < 0.05) ( Table 2) .
Patients receiving intraoperative clonidine (groups B, C, D) presented less haemodynamic reactions at the moment of skin incision (P<O.Ol). There were no significant differences at peritoneal incision and retractor placement (Figure 1) . In group D, no modifications of the ECG were noted after bolus injection of lignocaine.
Fourteen patients felt abdominal pain requiring a PCA bolus immediately after tracheal extubation. Eight of those subjects were in group A and two in each other group (P<O.OI). Meanwhile, the time interval between tracheal extubation and the first PCA requirement did not significantly differ among the four groups (A = 37 ± 17 min, B = 36 ± 12 min, C = 81 ± 23 min, D = 52 ± 21 min).
Analgesic demands (both met and unmet) were significantly reduced in groups B, C, D at any time interval considered, compared with group A (P<O.Ol).
No differences were noted, however, between groups B, C, D (Figure 2) .
Morphine cumulative doses are presented in Figure  3 . Morphine requirements were significantly lower in groups B, C, D than in group A. They were also lower in group D in comparison with groups Band C. This difference, however, did not reach statistical signi ficance.
Patients having received intraoperative clonidine (groups B, C, D) reported better pain score at any interval considered than patients in group A (P<O.OOl) ( Figure 4 ). showing a haemodynamic reaction (20070 increase in preincisional heart rate and/or mean arterial blood pressure) after skin incision (I), peritoneum incision (2) and retractor placement (3). 
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12h 18h 24h 36h At the end of the observation period, patient satisfaction scores were also lower in this group. Thirty-three per cent of the patients in group A reported their analgesia as excellent vs 73070 in group B, 95% in group C and 84% in group D (P<O.OI).
No patient developed bradypnoea, hallucinations, prolonged ileus or metallic taste.
No patient developed any hypotensive event during or after the procedure. No rebound hypertension was noted in the clonidine-treated groups during the first postoperative week.
The clinical course was uncomplicated in all patients.
DISCUSSION
As reported in our previous study,4 the intraoperative use of clodinine improved morphine patient-controlled analgesia. It reduced the analgesic demands, the morphine requirements, it improved the pain analogue scales and the patient satisfaction regarding postoperative analgesia. Moreover, it also reduced the incidence of side-effects.
Clonidine, a highly liposoluble central-acting alpha2-adrenergic agonist, has analgesic properties. acting on the spinal dorsal horn neurones of the lamina IV and V by an alpha2-adrenergic receptor, 12·14 recruitment of other neuromediators that can modulate the pain perception (adenosine, acetylcholine, endorphins}"·16 and inhibition of substance P release. 17 In animal models of acute pain, controversial reports exist regarding the efficacy of clonidine alone. An analgesic effect was demonstrated in an acute visceral pain model. 16 ." The somatosensory organisation of visceral pain differs from that of somatic pain 19 and clonidine may have specific visceral antinociceptive effects. Moreover, several experimental and clinical studies have demonstrated a potentiation of the antinociceptive effect of morphine by systemic clonidine administration. 20 Alpha2-adrenergic agonists also have a beneficial effect on the psychoemotive component of pain,>' reducing the postoperative emotional distress. 22 Large doses of clonidine (4 J.tg.kg-I ) given before surgical incision may have prevented the post-injury spinal hyperactivity and limited the magnitude of postoperative pain. Nociceptive afferents initiate modifications in the central nervous system, inducing allodynia, hyperalgesia, persistent pain and referred pain. Persistent depolarisation of the spinal dorsal horn interneurones plays a critical role in this amplification of the pain sensation. 23 .
Preincisional infiltrations
with local anaesthetics or opiate premedication have already been reported to attentuate postoperative pain. 25.26 This loading dose of clonidine is an extrapolation of the doses usually advocated for oral premedication.27 A slow infusion rate was chosen to avoid the vasoconstrictive effects of IV clonidine. At the end of such an infusion, the plasma levels of clonidine approximate 2.5 to 3 ng.ml-I (unpublished data). It was followed by a continuous infusion of 2 Jlg.kg.h -I, having in mind the analgesic characteristics of epidural clonidine. 28 Clonidine seems to produce analgesia at doses lower than those required to cause hypotension. Clonidine probably induces hypotension by agonist activity at the imidazolin-preferring receptor in the nucleus reticularis lateralis and analgesia by agonist activity at the alpha2-adrenergic receptor in the locus coeruleus.
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Experimentally, the dose of clonidine required to abolish the spontaneous firing rate of the nucleus reticularis is lower than that required to abolish the spontaneous firing rate of the locus coeruleus.
Intraoperative clonidine was the major determinant of the reduction in analgesic demands and morphine requirements in this study. Postoperative administration of clonidine despite significant doses (±O.3 Jlg.kg-I.h -I, approximating the same doses as used by Bernard et al.) 10 failed to produce significant additional benefits over intraoperative administration.
Intra-and postoperative administration of lignocaine failed to result in any significant benefits. Local anaesthetics produce a block in the conduction of the action potentials by combination with the sodium channels when applied directly to nervous tissue. 30 The general effects of those drugs imply that they have a selective central action. The depression of synaptic transmission is probably the mechanism involved in this central antinociceptive action. 31 In the present study IV bolus of 2 mg.kg-I was given just before the painful surgical stimulations (skin and peritoneal incision, retractor placement). This dose was reported to blunt the haemodynamic reaction at intubation. 32 Pain impulses from the operative area are carried to the central nervous system by afferent A-delta and C-fibres. Low doses of lignocaine markedly attenuated activity in cardiac C-fibres after cardiac ischaemia. 33 The systemic administration of lignocaine reduces acute postoperative pain. 7 • 34 In the postoperative period lignocaine 23 mg was given per request. It represents a very low dosage in comparison with the continuous infusion used by Cassuto et al. 34 This low dosage probably explains the lack of significant analgesic benefits in the lignocaine group. It was, however, chosen having in mind the synergistic effects between alpha2-adrenergic agonists and local anaesthetics in regional anaesthesia. R. 9 In the postoperative period, morphine, clonidine and lignocaine were given by the PCA device. Unequal morphine boluses were chosen for the different groups. Patients in group A received the largest morphine bolus (2 mg) and patients in group D the smallest (1.2 mg). On the one hand, it seems logical to reduce the morphine dose when other analgesics are added, but on the other hand such a methodological difference may have biased the interpretation of the morphinesparing effect. The consideration of the analgesic demands (met and unmet), however, offset this problem. The use of PCA in the assessment of pain and pain relief has been suggested as a reliable tool in studies of pain. 35 The examination of the pattern and timing of analgesic demands (both met and unmet) during the postoperative course is an adequate method of quantification of pain and the effects of analgesic given.
Both clonidine and lignocaine, by reduction of the hepatic blood flow or direct competition with the metabolic pathways, may have prolonged the half-life of morphine. 36 • 37 The reduced rate of side-effects (nausea, vomiting, sedation) in the clonidine groups is, however, an argument against a pure pharmaco kinetic interaction.
This clinical investigation is another demonstration of the beneficial effect of clonidine on opioid postoperative analgesia. It demonstrated that intraoperative clonidine was the major determinant of the morphinesparing effect, without increasing sedation or sideeffects.
Lignocaine, at the dose used, failed to afford any significant additional benefits.
